Alzheimer’s is a debilitating neurodegenerative and neuroinflammatory disease that is difficult to treat. Most existing therapies target the buildup of Amyloid Beta Plaques in the brain, which requires early intervention and intravenous therapy. But in Alzheimer’s mouse models, the new nasal immunotherapy — anti-CD3 — reduced inflammation and improved cognition independent of amyloid beta plaques. […]